PhaseWell Research

PhaseWell Research (“PhaseWell”) is a clinical research site company united by a shared commitment to advance the future of medicine. With a national network of high-performing sites, PhaseWell delivers comprehensive Phase I–IV clinical trial services across a broad range of therapeutic areas—including oncology, central nervous system (CNS), cardiovascular/metabolic, and dermatology. PhaseWell’s team of physicians and investigators are recognized industry leaders, known for their clinical expertise and operational excellence. By leveraging proven recruitment strategies and deep access to diverse patient populations through robust databases and strategic partnerships, PhaseWell has successfully completed more than 1,400 clinical trials and contributed to the approval of over 150 therapies. To learn more about PhaseWell Research, please visit www.phasewell.com.